North America SPECT Equipment Market Analysis, Size, and Share by 2028

The SPECT equipment market in North America is expected to grow from US$ 677.68 million in 2021 to US$ 935.36 million by 2028; it is estimated to grow at a CAGR of 4.7% from 2021 to 2028.

Increasing prevalence of atherosclerotic CVD in several countries is the ongoing change in nutrition patterns and thus, affecting the people adversely. SPECT equipment is mainly used by doctors to diagnose coronary artery disease. Myocardial perfusion imaging (MPI) using nuclear cardiology techniques has been widely applied in clinical settings because of its well-documented value in the diagnosis and prognosis of coronary artery disease. The half-life of technetium-99m, the radiotracer used for SPECT is around six hours, which means technologists/radiologists have ample time to perform the imaging that is required. This is how they are able to perform nuclear stress tests. SPECT is much more widely available than PET. It is more affordable, with the average camera costing between US$ 400,000 and US$ 600,000. Owing to its widespread use, there is an availability of more trained technologists in this field. The longer half-life of the SPECT radiotracer makes it more widely available and ideal for cardiac stress testing. The rising improvements in radiotracer and camera technology are expected to boost the image quality, helping to overcome a common SPECT complaint. It has been commonly reported that SPECT resolution is at 12 mm to 15 mm, and images can be prone to attenuation on older cameras. So, increasing growth of cardiovascular diseases in several economies is expected to drive the SPECT equipment market

Countries falling under North America were highly impacted by Covid-19 in the initial stages, i.e., during the first wave, and impacted the U.S. SPECT equipment market. As per the Society of Nuclear Medicine and Molecular Imaging (SNMMI), nearly 80% of respondents saw declines of 50%-75% in nuclear medicine imaging procedures. In the U.S., due to an increasing number of infected patients and lethal Coronavirus variants, the diagnostic and imaging activities had come to an end for an extended period during the pandemic. Thus, overall diagnosis of chronic diseases with SPECT equipment got delayed and hampered the North American SPECT equipment market. Therefore, the COVID-19 has a potential economic impact on most sectors, including oncology procedures. The pandemic has hindered cancer diagnosis and surgeries and is likely to impact the market negatively. For instance, in 2020, Breastcancer.org conducted a survey in 534 patients in the U.S., which revealed that around 31.7% of people who had been diagnosed with breast cancer reported a delay in care; of these people, 22% reported delayed in screening, and 9.3% reported a delay in treatment due to COVID-19. As a result, more cases of advanced cancers are expected in coming years due to delayed diagnosis, such as preventative screening and postponed medical appointments, in the coming years. The SPECT Equipment market in the U.S. is expected to witness modest growth driven by an aging population, increases in health risk factors like poor lifestyle, and the adoption of new technology due to favorable regulatory changes. However, the overall market expansion will be hindered by a saturated installed base of large imaging systems and the consolidation of hospitals. Also, the pandemic has dramatically affected the activities in radio isotopes field globally. In many radio pharmacy labs, diagnostic imaging tests are quantitatively reduced, and certain imaging centers reduce their test procedures to a significant extent. Thus, the market for SPECT Equipment region is expected to witness negative growth for a certain period.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the SPECT equipment market. The North America SPECT equipment is expected to grow at a good CAGR during the forecast period.

  North America SPECT Equipment Market Revenue and Forecast to 2028 (US$ Million)

 

North America SPECT Equipment Market Segmentation

North America SPECT Equipment Market – By Type

• Hybrid SPECT
  • SPECT-CT
  • SPECT-MR
• Standalone SPECT

North America SPECT Equipment Market – By Radioisotopes

•  Iodine-123
•  Technetium-99m
•  Xenon-133
•  Thallium-201
•  Ra-223
•  Ga-66
•  Other Radioisotopes

North America SPECT Equipment Market – By Application

• Seizures
•  Stroke
•  Stress Fractures
•  Infections
•  Tumors
•  Others

North America SPECT Equipment Market – By End User

• Hospitals
•  Imaging Centers
•  Others

North America SPECT Equipment Market- By Country

• US
• Canada
• Mexico

North America SPECT Equipment Market-Companies Mentioned

• Bracco Imaging S.p.A.
• Bruker Corporation
• Cardinal Health, Inc
• Curium
• Lantheus Medical Imaging Inc.
• Mediso Ltd.
• MiE GmbH
• NTP RADIOISOTOPES
• Star Equity Holdings Ltd.

North America SPECT Equipment Report Scope